Clinical Trial Update: Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the effectiveness of combining Arimidex (anastrozole) and Nolvadex (tamoxifen) as adjuvant therapy for breast cancer in postmenopausal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• Nolvadex (tamoxifen)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED